The 2025-2030 World Outlook for Spinal Cord Stimulators - Image 1

Out of Stock

This item is currently unavailable

The 2025-2030 World Outlook for Spinal Cord Stimulators

Subjects

Out of Stock

Price data last checked 120 day(s) ago - refreshing...

View at Amazon

One email. No newsletter. No nudges.

Gone for 182 days. Could come back at any time — we're watching for you.

Out of stock 182 days · last price £790 · longest previous gap was 1 days

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 250 days • 250 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 250 days • 1 price levels

Days at Price

Price Analysis

Most common price: £790 (250 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 250 days

Description

This study covers the world outlook for spinal cord stimulators across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of spinal cord stimulators as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include Abbott, Autonomic Technologies, Boston Scientific Corporation, Codman & Shurtleff, Integer Holdings, IntraPace, LivaNova, Mainstay Medical, Medtronic Private, Ltd. Company, Neuronetics, Nevro, Nuvectra, Saluda Medical PTY, St. Jude Medical, and Stimwave. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2024).

Product Specifications

Format: paperback
ASIN: B0CZ2CWQXL
Category: Books > Subjects
Domain: Amazon UK
Release Date: 03 March 2024
Listed Since: 26 April 2024

The 2025-2030 World Outlook for Spinal Cord Stimulators

Gone for 182 days. Could come back at any time — we're watching for you.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The Neuromodulation Casebook

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in India

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in Japan

The 2023 Report on Medical Electrodes: World Market Segmentation by City

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs in China

Spinal Cord Injury: Volume 109 (Handbook of Clinical Neurology, Volume 109)

Spinal Cord Stimulation: Percutaneous Implantation Techniques

The 2023-2028 Outlook for Antidepressant and Anti-Anxiety Drugs for US Zip Codes

Computational Neurostimulation (Volume 222) (Progress in Brain Research, Volume 222)

Spinal Cord Injury and Regeneration: 7 (AOSpine Masters Series)

The 2025-2030 World Outlook for Medical Electrodes

Atlas of Interventional Pain Management

Neurons, Circuitry, and Plasticity in the Spinal Cord and Brainstem, Volume 1279 (Annals of the New York Academy of Sciences)

The 2025-2030 World Outlook for Electrodes for Medical Devices

2023 Report on Interventional Oncology - World Market Data

Pain / Brain Stimulation in the Treatment of Pain (Disability Studies Series)

The 2026-2031 World Outlook for Arthroscopy and Sports Medicine Products

Stem Cell Technologies in Neuroscience: 126 (Neuromethods, 126)

Neural Prostheses for Restoration of Sensory and Motor Function (Methods and New Frontiers in Neuroscience)

The 2026-2031 World Outlook for Medical Device Connectivity

Stem Cell Technologies in Neuroscience: 126 (Neuromethods, 126)

Spinal Cord Monitoring: Basic Principles, Regeneration, Pathophysiology, and Clinical Aspects

The 2025-2030 World Outlook for Bone Growth Stimulators

Neuroprosthetics: Theory and Practice (Second Edition): 8 (Series On Bioengineering And Biomedical Engineering)